Biocryst Pharmaceuticals Inc Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014
Revenue & cost
Revenue 74.59M62.38M19.64M26.29M17.33M13.61M
Cost of Revenue 4.54M0.09M0.13M0.10M0.12M
Gross Profit 70.05M62.30M26.16M17.23M13.49M
Operating items
Research & Development 73.66M83.90M56.90M49.16M41.94M51.80M
Selling, General & Administrative 10.12M12.75M12.33M9.13M6.01M7.46M
Restructuring Costs 1.76M-0.10M
Other Operating Expenses 4.54M0.09M0.13M0.20M0.12M
Operating Expenses 88.33M96.74M69.23M60.18M48.05M59.38M
Operating Income -13.74M-34.36M-49.59M-33.89M-30.72M-45.77M
EBIT -13.74M-34.36M-49.59M-33.89M-30.72M-45.77M
Non-operating items
Interest & Investment Income 0.29M0.50M0.41M0.22M0.09M0.09M
Other Non Operating Income -4.00M-0.75M5.29M5.49M
Net income details
EBT -13.45M-33.85M-52.95M-38.33M-35.40M-50.68M
Profit After Tax -13.45M-33.85M-56.95M-39.08M-30.11M-45.19M
Income from Continuing Operations -13.45M-33.85M-52.95M-38.33M-35.40M-50.68M
Consolidated Net Income -13.45M-33.85M-52.95M-38.33M-35.40M-50.68M
Income towards Parent Company -13.45M-33.85M-52.95M-38.33M-35.40M-50.68M
Net Income towards Common Stockholders -13.45M-33.85M-52.95M-38.33M-35.40M-50.68M
Additional items
EPS (Basic) -0.35-0.76-1.26-0.79-0.55-0.68
Shares Outstanding (Weighted Average) 38.82M44.92M45.21M50.88M59.09M71.86M
EBITDA -13.74M-34.36M-57.01M-39.09M-30.13M-45.32M
Interest Expenses 3.77M4.67M4.78M5.00M